Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Fellner

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Plos One|February 6, 2014
Scalable passaging of adherent human pluripotent stem cellsYing Nie, Patrick Walsh, Diana L Clarke, et al.
Frontiers in Medicine|March 31, 2018
Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ LayersMehdi Shafa, Fan Yang, Thomas Fellner, et al.
Stem Cells and Development|March 31, 2009
Defining long-term maintenance conditions of human embryonic stem cells with arrayed cellular microenvironment technologyDavid A Brafman, Kevan D Shah, Thomas Fellner, et al.
Plos One|July 23, 2013
Headcase promotes cell survival and niche maintenance in the Drosophila testisLuís Pedro F Resende, Monica Boyle, Darrell Tran, et al.
Plos Biology|June 7, 2007
Generation of active protein phosphatase 2A is coupled to holoenzyme assemblyHans Hombauer, David Weismann, Ingrid Mudrak, et al.
Genes & Development|September 4, 2003
A novel and essential mechanism determining specificity and activity of protein phosphatase 2A (PP2A) in vivoThomas Fellner, Daniel H Lackner, Hans Hombauer, et al.
Stem Cell Reviews and Reports|June 11, 2016
Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic ApplicationsBehnam Ahmadian Baghbaderani, Adhikarla Syama, Renuka Sivapatham, et al.
Stem Cell Reports|November 29, 2013
Analysis of SOX2-expressing cell populations derived from human pluripotent stem cellsDavid A Brafman, Noel Moya, Stephanie Allen-Soltero, et al.
Plos One|September 9, 2016
A Newly Defined and Xeno-Free Culture Medium Supports Every-Other-Day Medium Replacement in the Generation and Long-Term Cultivation of Human Pluripotent Stem CellsBehnam Ahmadian Baghbaderani, Xinghui Tian, Jean Scotty Cadet, et al.
Stem Cell Reports|September 29, 2015
cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical ApplicationsBehnam Ahmadian Baghbaderani, Xinghui Tian, Boon Hwa Neo, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|February 6, 2014
Scalable passaging of adherent human pluripotent stem cellsYing Nie, Patrick Walsh, Diana L Clarke, et al.
Frontiers in Medicine|March 31, 2018
Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ LayersMehdi Shafa, Fan Yang, Thomas Fellner, et al.
Stem Cells and Development|March 31, 2009
Defining long-term maintenance conditions of human embryonic stem cells with arrayed cellular microenvironment technologyDavid A Brafman, Kevan D Shah, Thomas Fellner, et al.
Plos One|July 23, 2013
Headcase promotes cell survival and niche maintenance in the Drosophila testisLuís Pedro F Resende, Monica Boyle, Darrell Tran, et al.
Plos Biology|June 7, 2007
Generation of active protein phosphatase 2A is coupled to holoenzyme assemblyHans Hombauer, David Weismann, Ingrid Mudrak, et al.
Genes & Development|September 4, 2003
A novel and essential mechanism determining specificity and activity of protein phosphatase 2A (PP2A) in vivoThomas Fellner, Daniel H Lackner, Hans Hombauer, et al.
Stem Cell Reviews and Reports|June 11, 2016
Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic ApplicationsBehnam Ahmadian Baghbaderani, Adhikarla Syama, Renuka Sivapatham, et al.
Stem Cell Reports|November 29, 2013
Analysis of SOX2-expressing cell populations derived from human pluripotent stem cellsDavid A Brafman, Noel Moya, Stephanie Allen-Soltero, et al.
Plos One|September 9, 2016
A Newly Defined and Xeno-Free Culture Medium Supports Every-Other-Day Medium Replacement in the Generation and Long-Term Cultivation of Human Pluripotent Stem CellsBehnam Ahmadian Baghbaderani, Xinghui Tian, Jean Scotty Cadet, et al.
Stem Cell Reports|September 29, 2015
cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical ApplicationsBehnam Ahmadian Baghbaderani, Xinghui Tian, Boon Hwa Neo, et al.
Pageof 1